Exact Sciences Dividenda 2024

Detalji o dividendama

Razumevanje dividendnih isplata od Exact Sciences

Dividende od Exact Sciences su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od Exact Sciences tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od Exact Sciences su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od Exact Sciences mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

Exact Sciences Aktienanalyse

Шта ради Exact Sciences?

Exact Sciences Corp is a US-based company specializing in the development, manufacturing, and marketing of diagnostics. It was founded in 1995 by Kevin T. Conroy and is headquartered in Madison, Wisconsin. The company's main focus is on cancer diagnostics. It has developed an innovative test called the Cologuard test, which is a simple, non-invasive method for detecting colorectal cancer. The test can provide accurate results by analyzing a stool sample from the patient. The Cologuard test is FDA approved and recommended by physicians in the US. Exact Sciences has also developed an extensive portfolio of liquid biopsy tests, which can help detect cancer in its early stages by identifying changes in the patient's blood. The company aims to expand its position in the market for non-invasive cancer diagnostics. Originally founded as an oncology diagnostics company specializing in the development of tests for early tumor detection, Exact Sciences expanded its focus to colorectal cancer diagnostics in 2009 after acquiring the rights to a patented biomarker. The company has experienced rapid growth in recent years and has become a leader in the field of non-invasive cancer diagnostics. It has made several acquisitions, including the acquisition of Genomic Health, a provider of cancer diagnostics and molecular tests. Exact Sciences is divided into two business segments: 1. Diagnostics Exact Sciences develops and distributes diagnostics for the detection of various forms of cancer. The company has a range of products on the market, including: - Cologuard: A test for detecting colorectal cancer - Oncotype DX: A test for detecting various types of breast cancer - Oncotype MAP: A test for detecting colorectal and gastric cancer - Oncotype IQ: A platform for detecting various types of cancer 2. Research and Development Exact Sciences also conducts research and development in the field of cancer diagnostics. The company is working on developing tests for detecting many types of cancer in their early stages. It has also formed partnerships with other companies and organizations to support its research in this field. In conclusion, Exact Sciences Corp is an innovative company specializing in the development of diagnostics for the detection of various types of cancer. The company has achieved a strong market position in non-invasive cancer diagnostics and aims to further expand its product range. With the Cologuard test and its other diagnostics, the company has saved many lives and will continue to contribute to the early detection and treatment of cancer in the future. Exact Sciences je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o Exact Sciences akciji

Kolika je dividenda koju isplaćuje Exact Sciences?

U poslednjih 12 meseci, Exact Sciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Exact Sciences će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Exact Sciences?

Dividendski prinos od Exact Sciences trenutno iznosi .

Kada Exact Sciences isplaćuje dividendu?

Exact Sciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Exact Sciences?

Exact Sciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Exact Sciences?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Exact Sciences?

Exact Sciences se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Exact Sciences kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Exact Sciences od 3. 7. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 3. 7. 2024..

Kada je Exact Sciences poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 3. 7. 2024..

Kolika je bila dividenda od Exact Sciences u godini 2023?

U godini 2023 kompanija Exact Sciences je isplatila 0 USD kao dividende.

U kojoj valuti Exact Sciences isplaćuje dividendu?

Dividende od Exact Sciences se isplaćuju u USD.